FdaApplication

ANDA 212309

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBE PHARMACEUTICALS AG
application_typeANDA
approval_date2019-09-05

Products (1)

ProductActive ingredientStrengthDosage form
FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINEEQ 150MG BASE/VIALPOWDER;INTRAVENOUS

1 product